Section Arrow
Quote
PEN.NYSE
- Penumbra
Quotes are at least 15-min delayed:2026/04/28 03:13 EDT
Regular Hours
Last
 327.98
-1.91 (-0.58%)
Day High 
331.8 
Prev. Close
329.89 
1-M High
337.76 
Volume 
507.26K 
Bid
--
Ask
--
Day Low
327.75 
Open
329.91 
1-M Low
326.58 
Market Cap 
12.95B 
Currency 美元 
P/E 72.98 
%Yield -- 
10-SMA 331.15 
20-SMA 330.63 
50-SMA 335.4 
52-W High 362.41 
52-W Low 221.26 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
4.52/6.10
Enterprise Value
13.15B
Balance Sheet
Book Value Per Share
36.38
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
1.40B
Operating Revenue Per Share
25.36
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp59.95-2.12-3.42%31.99PE
ABTAbbott Laboratories92.8+1.67+1.83%24.5PE
PACBPacific Biosciences of California1.59+0.03+1.92%-- 
EWEdwards Lifesciences Corp83.46-0.69-0.82%46.49PE
MDTMedtronic plc82.92-0.4-0.48%23.27PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products inthe United States, followed by international markets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.